Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

JAZZ

Jazz Pharmaceuticals plc

Mar 18 • 04:00PM ET

139.51

Dollar change -0.71
Percentage change -0.51	%

Healthcare • Biotechnology • Ireland • NASD

Peers: VRTX REGN BIIB INCY GILD BMRN NBIX EXEL UTHR SAGE

| Held by: COWZ IJH VTI VB VBR VXF MDY IJJ SPMD DFAT

Scroll to Statements

Index	-	P/E	15.95	EPS (ttm)	8.75	Insider Own	4.54%	Shs Outstand	60.63M	Perf Week	1.94%
Market Cap	8.47B	Forward P/E	6.04	EPS next Y	23.09	Insider Trans	-1.30%	Shs Float	57.97M	Perf Month	4.14%
Income	560.12M	PEG	2.93	EPS next Q	4.82	Inst Own	97.55%	Short Float	7.53%	Perf Quarter	12.87%
Sales	4.07B	P/S	2.08	EPS this Y	11.99%	Inst Trans	2.04%	Short Ratio	5.67	Perf Half Y	28.24%
Book/sh	67.52	P/B	2.07	EPS next Y	-1.36%	ROA	4.79%	Short Interest	4.36M	Perf Year	17.93%
Cash/sh	49.28	P/C	2.83	EPS next 5Y	5.44%	ROE	14.31%	52W Range	99.06 - 148.06	Perf YTD	13.28%
Dividend Est.	-	P/FCF	6.24	EPS past 5Y	-1.00%	ROI	5.48%	52W High	-5.77%	Beta	0.36
Dividend TTM	-	Quick Ratio	3.99	Sales past 5Y	13.88%	Gross Margin	73.63%	52W Low	40.83%	ATR (14)	4.01
Dividend Ex-Date	-	Current Ratio	4.46	EPS Y/Y TTM	38.88%	Oper. Margin	17.86%	RSI (14)	58.19	Volatility	2.30% 3.08%
Employees	2800	Debt/Eq	1.51	Sales Y/Y TTM	6.12%	Profit Margin	13.77%	Recom	1.33	Target Price	193.94
Option/Short	Yes / Yes	LT Debt/Eq	1.50	EPS Q/Q	133.60%	Payout	0.00%	Rel Volume	0.83	Prev Close	140.22
Sales Surprise	2.84%	EPS Surprise	12.60%	Sales Q/Q	7.53%	Earnings	Feb 25 AMC	Avg Volume	769.43K	Price	139.51
SMA20	0.66%	SMA50	7.31%	SMA200	18.91%	Trades		Volume	636,962	Change	-0.51%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-25	Upgrade	UBS	Neutral → Buy	$145 → $179
Feb-26-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Feb-13-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$130 → $170
Dec-12-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$140 → $175
Jun-05-24	Initiated	Goldman	Buy	$169
Jan-03-24	Initiated	Robert W. Baird	Outperform	$160
Nov-27-23	Downgrade	UBS	Buy → Neutral	$170 → $135
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight	$184 → $140
Dec-09-22	Upgrade	Goldman	Neutral → Buy	$192 → $190
Jun-14-22	Initiated	UBS	Buy	$194
Apr-06-22	Downgrade	Goldman	Buy → Neutral	$202 → $196
Nov-19-21	Resumed	Goldman	Buy	$198
Oct-07-21	Resumed	Jefferies	Buy	$172
Oct-05-21	Initiated	Citigroup	Buy	$200
Sep-23-21	Initiated	Needham	Buy	$220
May-19-21	Resumed	JP Morgan	Overweight	$183 → $206
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$186
Feb-05-21	Reiterated	H.C. Wainwright	Buy	$195 → $207
Feb-03-21	Upgrade	Piper Sandler	Neutral → Overweight	$150 → $175

Show Previous Ratings

Mar-17-25 11:21AM	Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points (Investor's Business Daily)
07:53AM	Five Irish Stocks Near Buy Points To Add Green To Your Portfolio On St. Patrick's Day (Investor's Business Daily)
Mar-14-25 09:40AM	Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock (Zacks)
Mar-12-25 06:00AM	Bull of the Day: Jazz Pharmaceuticals (JAZZ) (Zacks)
Mar-09-25 06:09PM	Why Chimerix, Inc. (CMRX) Soared Last Week (Insider Monkey)
01:03PM	Loading…
Mar-05-25 01:03PM	Jazz Pharmaceuticals bids for Chimerix in $935m deal (Pharmaceutical Technology)
07:00AM	Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio (PR Newswire)
06:53AM	Jazz expands in oncology with $935M deal for Chimerix (BioPharma Dive)
Mar-04-25 08:07AM	3 Small-Cap Stocks Skating on Thin Ice (StockStory)
Mar-03-25 06:51PM	Jazz Pharmaceuticals plc (JAZZ): Among the Cash-Rich Mid Cap Stocks to Buy Now (Insider Monkey)
12:20PM	Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy? (Zacks)
09:55AM	Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High? (Zacks)
Feb-28-25 09:45AM	Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
09:15AM	International Markets and Jazz (JAZZ): A Deep Dive for Investors (Zacks)
Feb-26-25 10:53AM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
09:40AM	Loading…
09:40AM	Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term (Zacks)
02:14AM	Jazz Pharmaceuticals PLC (JAZZ) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Feb-25-25 06:30PM	Compared to Estimates, Jazz (JAZZ) Q4 Earnings: A Look at Key Metrics (Zacks)
05:45PM	Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates (Zacks)
05:33PM	Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 Sales (StockStory)
04:43PM	Jazz: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance (PR Newswire)
Feb-24-25 08:02AM	Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-20-25 04:15PM	Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference (PR Newswire)
09:15AM	Jazz (JAZZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Feb-12-25 09:25AM	Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains? (Zacks)
Feb-11-25 04:15PM	Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 (PR Newswire) +5.24%
Feb-05-25 12:10PM	Why Jazz (JAZZ) is Poised to Beat Earnings Estimates Again (Zacks)
Jan-15-25 01:57PM	JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline (Clinical Trials Arena)
01:54PM	Jazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks Now (Insider Monkey)
04:15PM	Loading…
Dec-17-24 04:15PM	Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-16-24 04:05PM	Jazz Pharmaceuticals Announces CEO Succession Plan (PR Newswire)
Dec-13-24 08:00AM	Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch (TipRanks)
Dec-06-24 04:05PM	Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting (PR Newswire)
11:31AM	Jazz (JAZZ) Up 3.4% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-05-24 07:45AM	Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii (Ziihera) (PR Newswire)
Dec-04-24 04:15PM	Jazz Pharmaceuticals Announces Ziihera (zanidatamab-hrii) Investor Webcast on December 11, 2024 (PR Newswire)
Dec-03-24 07:49AM	Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting (PR Newswire)
Nov-29-24 09:55AM	Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet (Zacks)
Nov-28-24 05:50AM	Why Jazz Pharmaceuticals (JAZZ) Is One of the Most Undervalued Pot Stocks to Buy? (Insider Monkey)
Nov-22-24 06:36AM	Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler (TipRanks)
Nov-20-24 07:19PM	Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) (PR Newswire)
Nov-19-24 04:05PM	Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference (PR Newswire)
09:40AM	Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? (Zacks)
08:29AM	Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a High Uncertainty With Low Risk Investment (Insider Monkey)
Nov-18-24 08:30AM	Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
Nov-14-24 08:46AM	Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock? (Zacks)
Nov-13-24 12:00PM	Jazz (JAZZ) Upgraded to Buy: Here's Why (Zacks)
09:55AM	Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High? (Zacks)
Nov-11-24 12:29PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
09:15AM	Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know (Zacks)
Nov-08-24 05:00AM	Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value (BioPharma Dive)
Nov-07-24 07:22PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research) +6.75%
02:20AM	Jazz Pharmaceuticals PLC (JAZZ) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-06-24 07:00PM	Compared to Estimates, Jazz (JAZZ) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Top Estimates (Zacks)
04:49PM	Jazz: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results (PR Newswire)
Nov-04-24 09:16AM	Insights Into Jazz (JAZZ) Q3: Wall Street Projections for Key Metrics (Zacks)
Oct-31-24 04:05PM	Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia (PR Newswire)
Oct-30-24 10:01AM	Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-27-24 02:00AM	Jazz Pharmaceuticals plc (JAZZ): Among the Best Stocks to Buy for High Returns in 2024 (Insider Monkey)
Oct-24-24 08:30AM	Jazz Pharmaceuticals price target raised to $179 from $175 at RBC Capital (TipRanks)
Oct-23-24 04:15PM	Jazz Pharmaceuticals to Report 2024 Third Quarter Financial Results on November 6, 2024 (PR Newswire)
Oct-18-24 04:34PM	Avadel wins FDA approval for narcolepsy drug Lumryz in children (Pharmaceutical Technology)
05:21AM	Billionaire Seth Klarman Sold 64% of Baupost's Stake in Alphabet and Is Piling Into This Historically Cheap and Under-the-Radar Drugmaker (Motley Fool)
Oct-17-24 09:55AM	Wall Street Analysts Think Jazz (JAZZ) Could Surge 51.8%: Read This Before Placing a Bet (Zacks)
09:40AM	Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now? (Zacks)
Oct-16-24 03:55PM	Is Jazz Pharmaceuticals plc (JAZZ) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
08:54AM	Is Jazz Pharmaceuticals (JAZZ) the Best Small-Cap Value Stock to Buy According to Hedge Funds? (Insider Monkey)
07:35AM	Jazz Pharmaceuticals Zepzelca combination meets endpoints in lung cancer trial (TipRanks)
Oct-15-24 11:50AM	Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer (Benzinga) +5.63%
10:31AM	PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer (PR Newswire)
07:30AM	Jazz Pharmaceuticals Announces Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer (PR Newswire)
06:47AM	Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data (BioPharma Dive)
Oct-14-24 09:52AM	Wall Street Analysts Favor Jazz Pharmaceuticals plc (JAZZ) for Biopharma Growth (Insider Monkey)
Oct-11-24 12:32PM	Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-09-24 04:15PM	Jazz Pharmaceuticals plc (JAZZ): Among The Stocks With Biggest Upside Potential According to Hedge Funds (Insider Monkey)
Oct-08-24 04:22AM	Jazz Pharmaceuticals Plc (JAZZ): Among Seth Klarmans Top Stock Picks (Insider Monkey)
Oct-04-24 10:00AM	Jazz Pharmaceuticals: Unveiling Growth Potential From Non-Small Cell Lung Cancer Market (GuruFocus.com)
Oct-03-24 07:40AM	Jazz Pharmaceuticals plc (JAZZ): Why Are Hedge Funds Bullish On This Cheap Growth Stock Right Now? (Insider Monkey)
Oct-01-24 09:40AM	Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now? (Zacks)
Sep-16-24 07:30AM	Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024 (PR Newswire)
Sep-09-24 07:58AM	Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024 (PR Newswire)
Sep-07-24 10:17PM	Jazz Pharmaceuticals plc (JAZZ): Why Do Hedge Funds Recommend This Biotech Stock? (Insider Monkey)
Sep-05-24 07:30AM	Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex/Epidyolex (cannabidiol) at the European Epilepsy Congress 2024 (PR Newswire)
01:07AM	Jazz Pharmaceuticals plc (JAZZ): Among the Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Sep-04-24 12:12AM	Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases (PR Newswire)
Sep-03-24 07:00AM	Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases (PR Newswire) -5.74%
Sep-02-24 06:05PM	10 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Aug-30-24 11:31AM	Why Is Jazz (JAZZ) Up 1.1% Since Last Earnings Report? (Zacks)
01:16AM	Jazz Pharmaceuticals plc (JAZZ): Top ADR Stock According to Hedge Funds (Insider Monkey)
Aug-23-24 10:13AM	Jazzs cannabidiol therapy flunks in Japanese Phase III trial (Pharmaceutical Technology)
Aug-22-24 04:05PM	Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies (PR Newswire)
Aug-21-24 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences (PR Newswire)
Aug-06-24 09:55AM	Wall Street Analysts Believe Jazz (JAZZ) Could Rally 56.66%: Here's is How to Trade (Zacks)
09:40AM	Is Jazz Pharmaceuticals (JAZZ) a Great Value Stock Right Now? (Zacks)
Aug-05-24 04:06PM	The 3 Best Cannabis Stocks to Buy in August 2024 (InvestorPlace)
09:15AM	Investing in Jazz (JAZZ)? Don't Miss Assessing Its International Revenue Trends (Zacks)
Jul-31-24 10:36PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Iannone Robert	EVP, Global Head of R&D & CMO	Mar 10 '25	Sale	138.41	2,403	332,605	79,621	Mar 12 02:24 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 10 '25	Sale	137.81	1,140	157,103	7,012	Mar 11 06:17 PM
Iannone Robert	Officer	Mar 10 '25	Proposed Sale	145.00	1,767	256,215		Mar 10 06:01 PM
Carr Patricia	Officer	Mar 10 '25	Proposed Sale	137.81	1,140	157,103		Mar 10 05:36 PM
Iannone Robert	EVP, Global Head of R&D & CMO	Mar 07 '25	Sale	138.60	7,080	981,298	82,024	Mar 07 06:49 PM
ROBERT IANNONE	Officer	Mar 07 '25	Proposed Sale	138.73	5,466	758,305		Mar 07 05:14 PM
Iannone Robert	Officer	Mar 07 '25	Proposed Sale	142.26	4,017	571,476		Mar 07 05:04 PM
Henderson Mary Elizabeth	Officer	Mar 07 '25	Proposed Sale	139.00	1,295	180,005		Mar 07 03:15 PM
Carr Patricia	SVP, Chief Accounting Officer	Feb 27 '25	Option Exercise	113.77	4,813	547,562	12,737	Mar 03 07:21 PM
Carr Patricia	SVP, Chief Accounting Officer	Feb 27 '25	Sale	144.42	4,813	695,075	8,237	Mar 03 07:21 PM
Carr Patricia	SVP, Chief Accounting Officer	Feb 28 '25	Sale	143.29	773	110,767	9,485	Mar 03 07:21 PM
Patil Neena M	EVP & Chief Legal Officer	Feb 27 '25	Sale	144.87	3,800	550,506	33,318	Mar 03 07:18 PM
COZADD BRUCE C	Chairman & CEO	Mar 03 '25	Sale	144.25	6,500	937,625	464,058	Mar 03 07:13 PM
COZADD BRUCE C	Officer	Mar 03 '25	Proposed Sale	144.25	6,500	937,625		Mar 03 04:44 PM
Carr Patricia	Officer	Feb 28 '25	Proposed Sale	143.30	773	110,767		Feb 28 05:43 PM
Carr Patricia	Officer	Feb 27 '25	Proposed Sale	139.00	1,641	228,099		Feb 27 08:05 PM
Carr Patricia	Officer	Feb 27 '25	Proposed Sale	144.42	4,813	695,075		Feb 27 05:04 PM
Patil Neena M	Officer	Feb 27 '25	Proposed Sale	144.87	3,800	550,518		Feb 27 04:56 PM
COZADD BRUCE C	Chairman & CEO	Feb 03 '25	Sale	122.31	1,500	183,465	439,744	Feb 05 05:41 PM
COZADD BRUCE C	Officer	Feb 03 '25	Proposed Sale	122.31	1,500	183,465		Feb 03 05:04 PM
COZADD BRUCE C	Chairman & CEO	Jan 02 '25	Sale	123.43	1,500	185,145	425,525	Jan 06 04:22 PM
COZADD BRUCE C	Officer	Jan 02 '25	Proposed Sale	123.43	1,500	185,145		Jan 02 05:00 PM
COZADD BRUCE C	Chairman & CEO	Dec 02 '24	Sale	121.17	2,000	242,340	427,025	Dec 04 05:24 PM
Carr Patricia	SVP, Chief Accounting Officer	Dec 02 '24	Sale	122.49	53	6,492	6,596	Dec 04 05:20 PM
COZADD BRUCE C	Officer	Dec 02 '24	Proposed Sale	121.17	2,000	242,340		Dec 02 06:05 PM
Carr Patricia	Officer	Dec 02 '24	Proposed Sale	122.49	53	6,492		Dec 02 04:20 PM
Patil Neena M	EVP & Chief Legal Officer	Nov 08 '24	Sale	123.41	3,700	456,617	33,048	Nov 13 05:44 PM
Patil Neena M	Officer	Nov 08 '24	Proposed Sale	123.41	3,700	456,632		Nov 08 05:55 PM
COZADD BRUCE C	Chairman & CEO	Nov 01 '24	Sale	110.84	1,000	110,840	428,976	Nov 05 05:00 PM
COZADD BRUCE C	Officer	Nov 01 '24	Proposed Sale	110.84	1,000	110,840		Nov 01 03:19 PM
Henderson Mary Elizabeth	SVP, Technical Operations	Sep 06 '24	Sale	108.30	1,410	152,703	14,531	Sep 11 11:38 AM
Henderson Mary Elizabeth	Officer	Sep 06 '24	Proposed Sale	110.00	2,691	296,010		Sep 05 07:50 PM
Winningham Rick E	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:57 PM
Smith Mark Douglas	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:55 PM
RIEDEL NORBERT G	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:49 PM
ORiordan Anne	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:42 PM
O'Keefe Kenneth W	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:35 PM
McSharry Heather Ann	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:29 PM
Cook Jennifer E.	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:19 PM
Sohn Catherine A.	Director	Aug 05 '24	Proposed Sale	111.00	3,075	341,325		Aug 02 04:20 PM
Carr Patricia	SVP, Chief Accounting Officer	Jun 07 '24	Sale	108.83	163	17,738	6,596	Jun 11 08:15 PM
Patil Neena M	EVP & Chief Legal Officer	May 03 '24	Sale	109.65	5,000	548,250	36,629	May 07 05:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JAZZ

Jazz Pharmaceuticals plc

Upgrade your FINVIZ experience